European committee: Regulators should deny Merck’s Lagevrio

Feb 24, 2023, 6:56 AM | Updated: 8:48 am

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. A Europea...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. A European medical committee says regulators should reject Merck's COVID-19 treatment Lagevrio for European Union use, Friday, Feb. 24, 2023. The drugmaker says a European Medicines Agency committee has recommended marketing authorization refusal for the antiviral pill. (AP Photo/Seth Wenig, File)

(AP Photo/Seth Wenig, File)

A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators.

A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the European Union should be refused.

A statement from the agency says a committee that has been reviewing Merck’s application for more than a year concluded that the drug’s clinical benefit could not be demonstrated.

Merck said Friday that it plans to appeal the recommendation, which came from the Committee for Medicinal Products for Human Use.

The drugmaker noted that more than two dozen countries have already approved or authorized the pill, including the United States. More than 4 million people have been treated with Lagevrio.

The United Kingdom became the first country in the world to authorize the drug in November 2021.

Merck said in a statement that it remains confident that the anti-viral pill “has an important role to play in the COVID 19 treatment landscape.”

Lagevrio and Pfizer’s pill treatment, Paxlovid, hit the U.S. market more than a year ago. They offer an easier way than IV medicines to treat patients with early COVID-19 symptoms who are at risk of serious illness.

Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. U.S. regulators have said it should be used cautiously.

The U.S. Food and Drug Administration authorized the treatment in late 2021 with restrictions. It cannot be used on patients under age 18. It also isn’t recommended for pregnant women because of the potential for birth defects.

The agency also has said Merck’s drug should be considered for patients “for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.”

The European Medicines Agency said Merck submitted results from a study involving more than 1,400 unvaccinated adult patients. It also provided data from other studies and real-world use.

The agency said in a statement that it wasn’t possible to conclude that Lagevrio reduces the risk of hospitalization or death or shortens recovery time or illness in adults at risk of severe complications.

The FDA has said the drug is effective against the virus, but its advisory panel only narrowly endorsed the treatment. The FDA authorized it in December 2021.

Lagevrio brought in about $5.7 billion in sales last year for Merck & Co. Inc., which is based in Rahway, New Jersey. Merck makes the treatment with Ridgeback Biotherapeutics.

For 2023, Merck forecasts about $1 billion in Lagevrio sales.

___

Follow Tom Murphy on Twitter: @thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

This photo provided by Robert Wilkes, owner of a house boat management company, shows smoke rising ...

Associated Press

Houseboats catch fire while docked at Wahweap Marina on Lake Powell

More than half a dozen house boats momentarily caught fire at a popular boating destination on the Utah-Arizona line on Friday.

23 hours ago

File - Women work in a restaurant kitchen in Chicago, Thursday, March 23, 2023. On Friday, the U.S....

Associated Press

US hiring, unemployment jump in May and what that says about the economy

The nation’s employers stepped up their hiring in May, adding a robust 339,000 jobs, well above expectations.

23 hours ago

(Pixabay Photo)...

Associated Press

Oath Keeper from Arizona sentenced for role in Jan. 6 riot at US Capitol

Edward Vallejo, a U.S. Army veteran from Phoenix, oversaw a “Quick Reaction Force” at a Virginia hotel that was prepared to deploy an arsenal of weapons into Washington if needed, authorities say.

2 days ago

FILE - U.S. Border Patrol Chief Raul Ortiz listens during a news conference, Jan. 5, 2023, in Washi...

Associated Press

US Border Patrol chief is retiring after seeing through end of Title 42 immigration restrictions

The head of the U.S. Border Patrol announced Tuesday that he was retiring, after seeing through a major policy shift that seeks to clamp down on illegal crossings at the U.S.-Mexico border following the end of Title 42 pandemic restrictions.

3 days ago

FILE - President Joe Biden talks with House Speaker Kevin McCarthy of Calif., on the House steps as...

Associated Press

House OKs debt ceiling bill to avoid default, sends Biden-McCarthy deal to Senate

The House approved a debt ceiling and budget cuts package late Wednesday, as President Joe Biden and Speaker Kevin McCarthy assembled a bipartisan coalition of centrist Democrats and Republicans against fierce conservative blowback and progressive dissent.

3 days ago

Sean Bickings (Family Photo via city of Tempe)...

Associated Press

Family of man who drowned last year in Tempe Town Lake files wrongful death lawsuit

The family of a man who drowned in Tempe Town Lake a year ago filed a wrongful death lawsuit against the city Wednesday, noting that its police department doesn't have a policy requiring officers to go into the water to save someone.

3 days ago

Sponsored Articles

...

Desert Institute for Spine Care

Spinal fusion surgery has come a long way, despite misconceptions

As Dr. Justin Field of the Desert Institute for Spine Care explained, “we've come a long way over the last couple of decades.”

...

re:vitalize

Why drug-free weight loss still matters

Wanting to lose weight is a common goal for many people as they progress throughout life, but choosing between a holistic approach or to take medicine can be a tough decision.

(Photo by Michael Matthey/picture alliance via Getty Images)...

Cox Communications

Valley Boys & Girls Club uses esports to help kids make healthy choices

KTAR’s Community Spotlight focuses on the Boys & Girls Club of the Valley and the work to incorporate esports into children's lives.

European committee: Regulators should deny Merck’s Lagevrio